TLIS
NASDAQTalis Biomedical Corporation
Price$4.41+0.00 (+0.00%)
2025-06-092025-08-29
Latest news
25 items- 13D/GAmendment: SEC Form SC 13D/A filed by Talis Biomedical CorporationSC 13D/A - Talis Biomedical Corp (0001584751) (Subject)
- SECSEC Form 15-12G filed by Talis Biomedical Corporation15-12G - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form 25-NSE filed by Talis Biomedical Corporation25-NSE - Talis Biomedical Corp (0001584751) (Subject)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form S-8 POS filed by Talis Biomedical CorporationS-8 POS - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form S-8 POS filed by Talis Biomedical CorporationS-8 POS - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form S-8 POS filed by Talis Biomedical CorporationS-8 POS - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form S-8 POS filed by Talis Biomedical CorporationS-8 POS - Talis Biomedical Corp (0001584751) (Filer)
- INSIDERLarge owner Leonard Braden Michael bought $44,240 worth of shares (30,100 units at $1.47) (SEC Form 4)4 - Talis Biomedical Corp (0001584751) (Issuer)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
- SECAmendment: Talis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K/A - Talis Biomedical Corp (0001584751) (Filer)
- INSIDERLarge owner Leonard Braden Michael bought $2,000 worth of shares (500 units at $4.00) (SEC Form 4)4 - Talis Biomedical Corp (0001584751) (Issuer)
- INSIDERLarge owner Leonard Braden Michael bought $642 worth of shares (151 units at $4.25) (SEC Form 4)4 - Talis Biomedical Corp (0001584751) (Issuer)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
- INSIDERLarge owner Leonard Braden Michael bought $56,137 worth of shares (14,382 units at $3.90) (SEC Form 4)4 - Talis Biomedical Corp (0001584751) (Issuer)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
- SECSEC Form 10-Q filed by Talis Biomedical Corporation10-Q - Talis Biomedical Corp (0001584751) (Filer)
- 13D/GAmendment: SEC Form SC 13G/A filed by Talis Biomedical CorporationSC 13G/A - Talis Biomedical Corp (0001584751) (Subject)
- INSIDERNew insider Leonard Braden Michael claimed ownership of 203,569 shares (SEC Form 3)3 - Talis Biomedical Corp (0001584751) (Issuer)
- 13D/GSEC Form SC 13G filed by Talis Biomedical CorporationSC 13G - Talis Biomedical Corp (0001584751) (Subject)
- SECSEC Form NT 10-Q filed by Talis Biomedical CorporationNT 10-Q - Talis Biomedical Corp (0001584751) (Filer)
- INSIDERSEC Form 3 filed by new insider Ferrari Patricia3 - Talis Biomedical Corp (0001584751) (Issuer)
- INSIDERSEC Form 3 filed by new insider Young John T. Jr.3 - Talis Biomedical Corp (0001584751) (Issuer)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
- SECTalis Biomedical Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Talis Biomedical Corp (0001584751) (Filer)
TLIS FAQ
7 questionsWhat does Talis Biomedical Corporation do?
Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is...Where does TLIS stock trade?
Talis Biomedical Corporation (TLIS) is listed on NASDAQ.What sector and industry is TLIS in?
Talis Biomedical Corporation operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.When did Talis Biomedical Corporation go public?
Talis Biomedical Corporation (TLIS) completed its IPO in 2021.What are analysts saying about TLIS?
Talis Biomedical Corporation has had 5 recent analyst actions on file. The most recent action was from BofA Securities: Underperform with a $300.00 price target on 2022-01-07. Recent price targets range from $300.00 to $1000.00.What companies are similar to TLIS?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare TLIS side-by-side with any of them on Quantisnow.How can I track TLIS on Quantisnow?
Quantisnow aggregates Talis Biomedical Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TLIS to receive live email and push alerts on every new disclosure.